A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that the location and pattern of these brain lesions are critical to assessing risk. Analyzing data from over 1,500 participants in the ARIC-Neurocognitive Study, researchers classified individuals based on their CMB patterns—lobar, subcortical, or mixed—and tracked dementia incidence. The results showed that participants with microbleeds in the lobar regions, which often indicate cerebral amyloid angiopathy, or a mixed pattern of bleeds had roughly double the risk of developing dementia compared to those with no CMBs. In contrast, individuals with microbleeds restricted to subcortical areas, typically linked to hypertension, did not show a significantly increased risk. The presence of cortical superficial siderosis (cSS) was associated with an even higher risk, and overall, a greater number of microbleeds anywhere in the brain correlated with higher dementia risk. The findings suggest that while the underlying cause of microbleeds matters, a severe disease burden is detrimental regardless of its location. Source: https://www.ahajournals.org/
A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2…
A comprehensive prospective study tracking over 159,000 adults for up to three decades has provided…
A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months…
A large-scale study involving 103,649 UK Biobank participants has revealed that adhering to healthy dietary…
To address uncertainties in statin safety profiles, which are often based on observational data susceptible…
In a Chinese phase 3 trial (LungTIME-C01) involving 210 patients with advanced non-small cell lung…
This website uses cookies.